<SEC-DOCUMENT>0001193125-20-048347.txt : 20200225
<SEC-HEADER>0001193125-20-048347.hdr.sgml : 20200225
<ACCEPTANCE-DATETIME>20200225161132
ACCESSION NUMBER:		0001193125-20-048347
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200225
FILED AS OF DATE:		20200225
DATE AS OF CHANGE:		20200225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nutrien Ltd.
		CENTRAL INDEX KEY:			0001725964
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				981400416
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38336
		FILM NUMBER:		20650736

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 500, 122 - 1ST AVENUE SOUTH
		CITY:			SASKATOON
		STATE:			A9
		ZIP:			S7K 7G3
		BUSINESS PHONE:		(306) 933-8500

	MAIL ADDRESS:	
		STREET 1:		SUITE 500, 122 - 1ST AVENUE SOUTH
		CITY:			SASKATOON
		STATE:			A9
		ZIP:			S7K 7G3
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d894066d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:20pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Report of
Foreign Issuer </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to <FONT STYLE="white-space:nowrap">Section&nbsp;13a-16</FONT> or
<FONT STYLE="white-space:nowrap">15d-16</FONT> of the </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of: February, 2020 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">001-38336</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>NUTRIEN LTD. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of
registrant) </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:20pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Suite 500, 122 &#150; 1st Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>South Saskatoon, Saskatchewan </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S7K 7G3 Canada </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address
of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:20pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT
STYLE="white-space:nowrap">40-F:</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form
<FONT STYLE="white-space:nowrap">20-F&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form</FONT> <FONT STYLE="white-space:nowrap">40-F&nbsp;&nbsp;&#9746;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT
STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>NUTRIEN LTD.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: February&nbsp;25, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert A. Kirkpatrick</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Robert A. Kirkpatrick</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SVP&nbsp;&amp; Corporate Secretary</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description of Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">News Release dated February&nbsp;25, 2020</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d894066dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:26pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g894066g65x82.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">NYSE, TSX: NTR</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>News Release</B></TD></TR>
</TABLE> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February 25, 2020 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman"><B>Nutrien Announces TSX Approval for Its Renewed Share Repurchase Program </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Saskatoon, Saskatchewan </B>&#150; Nutrien Ltd. (TSX and NYSE: NTR) (Nutrien) today announced that the Toronto Stock Exchange (TSX) has accepted
Nutrien&#146;s notice to commence a normal course issuer bid (NCIB) to purchase up to five percent of its outstanding common shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the NCIB,
purchases of common shares may be made through the facilities of the TSX, the New York Stock Exchange or alternative Canadian trading systems, or as otherwise permitted by the Canadian Securities Administrators. The actual number of common shares
that may be purchased under the NCIB and the timing of any such purchases will be determined by Nutrien. Nutrien believes that purchasing its own common shares represents an attractive investment opportunity, is in the best interests of the company
and is consistent with Nutrien&#146;s objective of delivering a strong return of capital to its shareholders over time. As of February 14, 2020, Nutrien had 571,449,161 common shares outstanding and, therefore, is permitted to repurchase up to
28,572,458 of its outstanding common shares pursuant to the NCIB. Common shares purchased under the NCIB will be cancelled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The NCIB will be effected in
accordance with the TSX normal course issuer bid rules and/or Rule 10b-18 under the U.S. Securities Exchange Act of&nbsp;1934, which contain restrictions on the number of common shares that may be purchased on a single day, subject to certain
exceptions for block purchases, based on the average daily trading volumes of Nutrien&#146;s common shares on the applicable exchange. Subject to exceptions for block purchases, Nutrien will limit daily purchases of common shares on the TSX in
connection with the NCIB to no more than 25&nbsp;percent (278,819 common shares) of the average daily trading volume of the common shares on the TSX (1,115,279 common shares) during any trading day. Purchases under the NCIB will be made through open
market purchases at market price, as well as by other means as may be permitted by applicable securities regulatory authorities, including private agreements. Any purchases made by private agreement under an issuer bid exemption order issued by a
securities regulatory authority will be at a discount to the prevailing market price as provided in any exemption order. Purchases of common shares may commence on February 27, 2020 and will expire on the earlier of February 26, 2021, the date on
which the company has acquired the maximum number of common shares allowable or otherwise decides not to make any further repurchases. Nutrien has entered into an automatic purchase plan with a broker which will enable Nutrien to provide standard
instructions and purchase common shares on the open market during self-imposed blackout periods. Outside of these black-out periods, common shares may be purchased in accordance with management&#146;s discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nutrien&#146;s prior NCIB for the purchase of up to 42,164,420 common shares will expire on February 26, 2020. As of February 14, 2020, Nutrien has
repurchased an aggregate of 31,984,768 common shares at a weighted-average price of US$51.91 per share, excluding brokerage fees, under the prior NCIB. Purchases were made on the open market. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certain statements and
other information included in this press release constitute &#147;forward-looking information&#148; or &#147;forward-looking statements&#148; (collectively, &#147;forward-looking statements&#148;) under applicable securities laws (such statements
are usually accompanied by words such as &#147;anticipate&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;may&#148;, &#147;will&#148;, &#147;should&#148;, &#147;estimate&#148;, &#147;intend&#148; or other similar words). All statements in this
press release, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to the timing, methods and quantity of any purchases by Nutrien of its common shares under the NCIB.
</I></P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Forward looking statements in this press release are based on certain key expectations and assumptions
made by Nutrien, including expectations and assumptions concerning: Nutrien&#146;s views with respect to its financial condition and prospects, the stability of general economic and market conditions, currency exchange rates and interest rates, the
availability of cash for repurchases of common shares under the NCIB, the existence of alternative uses for Nutrien&#146;s cash resources and compliance with applicable laws and regulations pertaining to the NCIB. Although Nutrien believes that the
expectations and assumptions on which such forward looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because Nutrien can give no assurance that they will prove to be correct. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Forward-looking statements are subject to various risks and uncertainties which could cause actual results and experience to differ materially from the
anticipated results or expectations expressed in this press release. The key risks and uncertainties include, but are not limited to: Nutrien&#146;s future capital requirements; market and general economic conditions; demand for Nutrien&#146;s
products; and unforeseen legal or regulatory developments and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulatory authorities and the United States Securities and Exchange Commission.
</I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this press release as a result of new
information or future events, except as may be required under applicable laws. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Nutrien </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nutrien is the world&#146;s largest provider of crop inputs and services, playing a critical role in helping growers increase food production in a sustainable
manner. We produce and distribute 25&nbsp;million tonnes of potash, nitrogen and phosphate products <FONT STYLE="white-space:nowrap">world-wide.</FONT> With this capability and our leading agriculture retail network, we are well positioned to supply
the needs of our customers. We operate with a long-term view and are committed to working with our stakeholders as we address our economic, environmental and social priorities. The scale and diversity of our integrated portfolio provides a stable
earnings base, multiple avenues for growth and the opportunity to return capital to shareholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FOR FURTHER INFORMATION: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor and Media Relations: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Richard Downey </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(403) 225-7357 </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tim Mizuno </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Manager, Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(306) 933-8548 </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contact us at: <U>w</U><U>w</U><U>w.n</U><U>u</U><U>t</U><U>ri</U><U>e</U><U>n.c</U><U>o</U><U>m</U> </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g894066g65x82.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g894066g65x82.jpg
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M,C(R,C(R,C(R,O_  !$( "@ FP,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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$0!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
